London, Ontario, Canada, 06 January, 2026 – KGK Science Inc., a leading full-service premium contract research organization (CRO) and regulatory consulting firm, today announced the publication of a …

London, Ontario, Canada, 06 January, 2026 – KGK Science Inc., a leading full-service premium contract research organization (CRO) and regulatory consulting firm, today announced the publication of a …

KGK Science has been delivering top-notch clinical research trials and expert regulatory support for the nutraceutical, cannabis, hemp, and psychedelic industries for over 27 years, aiding companies in …

Ready to collaborate? Contact KGK Science for CRO services, participant recruitment, regulatory services, clinical trial info, or media and investor inquiries.

London, Ontario, Canada – KGK Science Inc., a leading contract research organization specializing in clinical research and regulatory support for the nutraceutical industry, is pleased to announce the …

KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device KGK Science has been contracted by the Hamilton, Ontario-based neurotech firm, Zentrela Inc. to …

4 days ago · A randomized, triple-blind, placebo controlled, parallel clinical trial to investigate the safety and efficacy of Maizinol® on sleep quality in a healthy population with difficulty falling asleep or …

About Us The Science behind the success Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and …

Looking to grow in clinical research? Explore career opportunities at KGK Science and join a team committed to scientific excellence and innovation.

The study was conducted at KGK Science Inc. (London, Ontario, Canada) from January 14, 2023, to November 30, 2023. Notice of authorization was granted on October 31, 2022, by the Natural and …